From February 26, the medical cannabis division of Rokshaw Ltd is rebranding to Curaleaf Laboratories.
In 2019, Rokshaw joined the Curaleaf International group and, because of this, in August 2020, became a manufacturer of full-spectrum medical cannabis in the UK.
Despite the name change, the company will still be operating under the same MHRA license that has guaranteed the highest quality since our inception.
What's changing
- The "Rokshaw Medical Cannabis" website will be updated to "Curaleaf Laboratories" to match our new branding with a consistent style and feel.
- Contact details such as our phone number and orders email will be updated to align with the Curaleaf domain.
- The alignment to the Curaleaf name and ways of working to continue driving market access with new capabilities and infrastructure development.
- The current Rokshaw social media profiles will be repurposed to reflect our medical cannabis division and adopt the Curaleaf branding and handles.
What remains unchanged
- The same leadership and operational team are at the forefront of driving product and service excellence throughout the business.
- The MHRA license and manufacturing facility, as well as the quality management system (QMS) that guarantees the highest level of quality with every product.
- The limited company name of "Rokshaw Ltd" still applies across the organization, with this purely being a trading name change across the medical cannabis division.
- If you are already an existing customer, the account reference will remain unchanged.
Richard Hodgson, Managing Director of Curaleaf Laboratories: "My brother Jonathan and I started Rokshaw in 2012 with a vision of positively impacting the lives of patients all across the UK. We are extremely proud to look back and see how far we have come in our journey, making long-lasting relationships with customers along the way. Since joining the Curaleaf International, we have been on an upward trajectory, making waves in the emerging medical cannabis market. It feels like a natural step to adopt the Curaleaf name in this division of the business, to embrace the vision that we share and convey a transparent message to our customers and partners."
Jonathan Hodgson, CEO of Curaleaf Laboratories: "We see this as an extremely exciting day, as we adopt the Curaleaf name in our medical cannabis division of the business. We joined the Curaleaf International group in 2019 and have helped accelerate market access by becoming the first manufacturer of full-spectrum medical cannabis in the UK. Our reputation as a best-in-class manufacturer of unlicensed medicines for over a decade, coupled with the expertise that Curaleaf brings, is extremely exciting for the future. I'd like to thank all of our loyal customers and partners who have been with us on this journey so far, and we are excited to continue this journey with you."
For more information:
Curaleaf Laboratories
rokshaw.co.uk